FDA approves new Roche hospital glucose meter
The US Food and Drug Administration recently approved Roche's new blood glucose monitor, ACCU-CHEK Inform II, for use in hospital settings.
With this next-generation meter and test strip, medical personnel can obtain a patient's blood sugar level in five seconds, using only a 0.6 microliter blood sample, Roche's media release noted. The system's new patented technology allows it to provide accurate test results, eliminating potential interference from maltose, xylose and oxygen.
Further, the ACCU-CHEK Inform II affords the wireless transfer of patient data in real time between the hospital and the laboratory, the Chicago Tribune reported.
"ACCU-CHEK systems have been proven in hospitals around the world and this next-generation wireless system sets a new standard by offering U.S. health care professionals new capabilities to help ensure the accuracy of test results, streamline data communications and provide optimal patient care," Roland Diggelmann, chief operating officer at Roche Diagnostics, said in the media release.
The system is scheduled to be available for use in the US this month.
According to CNBC, the ACCU-CHEK Inform II is the third Roche diabetes product the FDA cleared this year.
FDA Clears ACCU-CHEK Inform II, Roche's New Hospital Point-Of-Care System For Blood Glucose Testing With Improved Accuracy and Wireless Data Transfer," Roche.com, October 16, 2012
"Roche Gets U.S. Approval for Hospital Glucose Monitor," ChicagoTribune.com, October 16, 2012
"Roche Gets U.S. Approval for Hospital Glucose Monitor," CNBC.com, October 16, 2012, Caroline Copley